image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Sanderson

December 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SDG
  • Price:
  • 118p
I originally wrote Sanderson up at 122p and the shares zoomed to a high of £2 before cost of living concerns started to bite. Nevertheless, interims to end July show growth has returned with adjusted pretax profit up 2.5% to £6.3m on sales 0.7% higher to £57.9m. Brand product sales fell 2.5% in spite of a sparkling 15.5% increase at Morris & Co. UK sales rose 20.8% and US +53.7%, but North Europe was down 20%, impacted by its exit from Russia. More positively, licensing sales grew 90% to £3.8m, with notable deals signed including 3-year renewal with Bedeck (bedding) and renewals with NEXT and Williams Sonoma (cookware). This is a huge coup for Sanderson because licencing income mostly falls straight to the bottom line and this helped ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author